The Oncology Institute, Inc. TOI EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s EPS (diluted)?
- The Oncology Institute, Inc. (TOI) reported EPS (diluted) of -$0.02 in Q1 2026.
- How has The Oncology Institute, Inc.'s EPS (diluted) changed year-over-year?
- The Oncology Institute, Inc.'s EPS (diluted) increased by 90.5% year-over-year, from -$0.21 to -$0.02.
- What is the long-term trend for The Oncology Institute, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s EPS (diluted) has grown at a 34.1% compound annual growth rate (CAGR), from -$0.17 to -$0.55.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.